logoAiPathly

Atropos Health

A

Overview

Atropos Health is a pioneering company in healthcare and life sciences, specializing in translating real-world clinical data into personalized real-world evidence (RWE) to improve clinical outcomes, accelerate research, and enhance operational efficiency. Key Features and Technologies:

  1. GENEVA OS™: A Generative Evidence Acceleration Operating System that securely installs on medical data, structuring it for use by clinicians, researchers, and data scientists. It enables rapid generation of high-quality, publication-grade real-world evidence.
  2. Atropos Evidence™ Network: Provides access to de-identified records of approximately 200 million global patients, allowing organizations to run queries and generate evidence quickly. It includes the Alexandria™ library, containing over 10,000 past studies across more than 40 clinical specialties.
  3. ChatRWD™ and Green Button™ Informatics Consult Service: Tools that allow users to ask clinical questions and receive evidence-based answers in minutes, facilitated by a chat-based AI co-pilot and supported by medical experts. Mission and Impact: Atropos Health aims to address the "evidence gap" in healthcare, particularly for patients with multiple comorbidities or from understudied groups. By democratizing access to high-quality RWE, the company seeks to personalize clinical decisions, optimize care protocols, and conduct population health studies more effectively. Applications and Benefits:
  4. Precision Medicine: Enhances precision medicine programs by providing personalized insights for diagnosis, treatment selection, and care management.
  5. Clinical Decision-Making: Accelerates appropriate clinical decision-making, driving high-value, low-cost care tailored to individual patient physiology.
  6. Research and Development: Expedites research by generating novel retrospective observational studies in response to clinical questions, reducing time from months to minutes.
  7. Cost Savings and Efficiency: Helps health systems reduce healthcare costs through optimized care protocols, lower research costs, and improved patient outcomes. Partnerships and Funding: Atropos Health has received significant funding, including a $33 million Series B round led by Valtruis. The company has strategic partnerships with health systems like Mayo Clinic, and life sciences companies such as Janssen and Novartis. Founding and Leadership: Founded in 2019 by Brigham Hyde, Ph.D., Nigam Shah, MBBS, Ph.D., and Saurabh Gombar, M.D., Ph.D., who are leaders in AI and real-world evidence research in healthcare. The company is headquartered in Palo Alto, CA, and has a strong advisory board of healthcare leaders.

Leadership Team

Atropos Health's leadership team comprises experienced professionals with diverse backgrounds in medicine, finance, and corporate development. Founders and Executive Leadership:

  1. Brigham Hyde, PhD: Co-Founder and Chief Executive Officer
  2. Saurabh Gombar, MD PhD: Co-Founder and Chief Medical Officer
  3. Nigam Shah, PhD MBBS: Co-Founder and Chief Data Scientist at Stanford Health Care Key Executives:
  4. Neil Sanghavi: President, Products & Solutions
  5. Sharath Reddy: Chief Financial Officer and Head of Corporate Development
  6. Vladimir Polony: Director of Engineering
  7. Yen Low, PhD: Director of Real-World Data & Data Science
  8. Cecily Harris: Legal
  9. Kris Karson: Corporate Development
  10. Rehan Chawdry: Engineering
  11. Joy Somogyi: Marketing
  12. Annie Daskovsky: Finance
  13. Kevin Smith: Health System Sales
  14. Chris Lento: Life Science Sales Advisory Boards: Atropos Health has both a Clinical Advisory Board and a Life Sciences Advisory Board, comprising healthcare industry leaders who advise on the company's strategies and innovations. Clinical Advisory Board Key Members:
  15. Nick Patel, MD: Chair of the Advisory Board
  16. Neera Ahuja, MD: Division Chief – Hospital Medicine at Stanford University School of Medicine
  17. Robert Harrington, MD: Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University
  18. Rasu Shrestha, MD, MBA: Chief Innovation and Commercialization Officer at Advocate Health Life Sciences Advisory Board Key Members:
  19. Barbara Salami: Former Vice President at Moderna
  20. Dr. Gabriel Eichler: Founder and Managing Director of Oak Health Partners This diverse leadership team brings a wealth of experience in healthcare, technology, and business, positioning Atropos Health at the forefront of AI-driven healthcare solutions.

History

Founding and Early Development:

  • Founded in 2019 as a spin-out of Stanford University's "Green Button" technology
  • Originated from a research project led by co-founders Brigham Hyde, Nigam Shah, and Saurabh Gombar
  • Aimed to leverage anonymized electronic medical records (EMRs) to inform patient care Key Milestones:
  1. Seed Funding and Initial Deployment (December 2020):
    • Announced launch and completion of seed funding round
    • Supported by Boston Millennia Founders Fund and others
    • Selected as a participant in StartX 2020
    • Deployed service within Stanford Health Care for two years
  2. Series A Funding (August 2022):
    • Raised $14 million led by Breyer Capital
    • Expanded commercial team and developed oncology product
    • Appointed Brigham Hyde as CEO
  3. Series B Funding (May 2024):
    • Secured $33 million to scale AI-powered real-world evidence platform
    • Focused on life sciences partnerships and international expansion Technological Advancements:
  4. Geneva OS (Fall 2023):
    • Includes ChatRWD chatbot interface
    • Reduces time to produce high-quality real-world evidence
  5. Atropos Evidence Platform:
    • Uses search technology licensed from Stanford University
    • Generated over 50 peer-reviewed studies
  6. Atropos Evidence Network:
    • Federal data network based on healthcare institution partners
    • Access to over 200 million unique de-identified patient records Significant Partnerships:
  • Janssen Research & Development
  • Cencora
  • Arcadia
  • xCures
  • Strategic funding from Presidio Ventures, Samsung Next, Gaingels, and Audere Capital Mission and Impact:
  • Aims to fill the evidence gap in healthcare
  • Provides personalized real-world data-driven evidence to caregivers
  • Improves patient outcomes and reduces healthcare expenditures
  • Saved clients over $100 million through expedited analytics and cost-saving measures Atropos Health's history reflects rapid growth and innovation in the field of AI-driven healthcare solutions, positioning the company as a leader in real-world evidence generation and application.

Products & Solutions

Atropos Health offers innovative solutions leveraging real-world data (RWD) to support clinical decision-making, research, and operational efficiency in healthcare and life sciences:

  1. Evidence Generation Solutions: Translates real-world clinical data into personalized real-world evidence (RWE) to close evidence gaps.
  2. GENEVA OS™: The Generative Evidence Acceleration Operating System securely installs on medical data, structuring it for use by clinicians, researchers, and data scientists. Users can ask clinical questions via ChatRWD™ or the Green Button™ Informatics Consult Service.
  3. Atropos Evidence™ Network and Alexandria™: Provides access to de-identified records of approximately 200 million global patients and a library of over 10,000 past studies across 40+ clinical specialties.
  4. Advanced Cohort Engine (ACE): Developed in collaboration with Stanford clinicians, ACE searches longitudinal patient records using Temporal Query Language (TQL).
  5. Real-Time Analytics and Comparative Effectiveness Research: Enables organizations to monitor interventions in real-time and optimize clinical operations, care pathways, and drug formularies.
  6. Clinical Decision Support: Accelerates appropriate clinical decision-making, supported by medical doctors, epidemiologists, statisticians, and other experts.
  7. Integration and Security: HIPAA-compliant and integrates with various health systems, allowing quick deployment and immediate access to the Atropos Evidence™ Network.
  8. Pricing and Accessibility: Available on platforms like AWS Marketplace, with pricing starting from $1.00/hr or $100.00/yr, plus AWS usage fees. Atropos Health's solutions aim to transform healthcare by providing rapid, methodologically credible real-world evidence, supporting better clinical decisions, research, and operational efficiency.

Core Technology

Atropos Health's core technology revolves around several key components that facilitate the use of real-world data (RWD) and artificial intelligence (AI) in healthcare:

  1. GENEVA OS™: The Generative Evidence Acceleration Operating System is designed for rapid healthcare evidence generation across a robust network of real-world data. It automates and standardizes evidence and insight generation for healthcare and life science institutions.
  2. Atropos Evidence™ Network: A federated healthcare data network providing access to over 300 million patient records. This network enables training, testing, and deployment of AI models using high-quality, de-identified real-world data, benefiting AI developers, health systems, life sciences organizations, and data holders.
  3. ChatRWD™: An AI co-pilot integrated with GENEVA OS™, using an LLM-independent framework to maintain security and integrity. It significantly reduces the time required to produce high-quality, publication-grade real-world evidence from months to minutes.
  4. Real-World Data (RWD) and Real-World Evidence (RWE): The platform leverages RWD to generate RWE, crucial for improving patient care and outcomes. This approach ensures AI models output accurate recommendations for researchers and clinicians, supporting precision medicine initiatives.
  5. Automation and Transparency: Built on principles of quality, transparency, and automation, Atropos Health prioritizes patient safety and responsible AI use. The technology ensures AI models are developed and deployed with emerging assurance standards on AI transparency and bias detection. Atropos Health's core technology combines these elements to provide a comprehensive platform for generating and utilizing real-world evidence in healthcare, supporting rapid clinical decision-making, research, and operational efficiency.

Industry Peers

Atropos Health operates within the digital health and healthcare analytics sector. Here are some of its key industry peers and competitors:

  1. Komodo Health: Specializes in healthcare analytics, providing insights from a range of healthcare data to improve patient care and reduce disease burden.
  2. Holmusk: Focuses on behavioral health, offering a real-world evidence platform leveraging AI-powered analytics and digital solutions.
  3. Evidation: Harnesses real-world health data to measure and improve health outcomes, serving life sciences companies, government bodies, and academic institutions.
  4. Tempus: Known for advanced genomic and transcriptomic analysis, providing personalized cancer treatment options and real-world evidence generation.
  5. Paradigm: While not exclusively focused on healthcare analytics, it competes with Atropos Health in terms of overall market presence and revenue scale.
  6. Datavant: Specializes in linking health data to improve patient outcomes, often mentioned alongside Atropos Health in industry analyses. Key Differentiators: Atropos Health stands out with its Evidence Network, allowing users to query a vast network of patient data (over 300 million patients) without data sales, ensuring HIPAA compliance and data security. It utilizes generative AI to produce real-world evidence reports quickly and at scale. Similarities: These companies share a focus on leveraging large datasets and advanced analytics to improve healthcare outcomes, optimize health systems, and accelerate clinical research. However, each has a unique approach and area of specialization within the broader healthcare technology landscape. Atropos Health's combination of a vast patient data network, generative AI capabilities, and focus on rapid, scalable evidence generation positions it uniquely in the competitive landscape of healthcare analytics and real-world evidence platforms.

More Companies

B

Blinkit

Blinkit, formerly known as Grofers, is a prominent Indian quick-commerce platform founded in December 2013 by Albinder Dhindsa and Saurabh Kumar. Based in Gurgaon, India, the company has revolutionized the grocery delivery sector with its innovative approach and rapid growth. ### Business Model Blinkit operates as an online grocery delivery service and quick-commerce platform, with the following key components: 1. **Marketplace Platform**: Customers can purchase a wide variety of goods, including groceries, bakery items, meats, and flowers, through Blinkit's eCommerce marketplace. 2. **Inventory Management**: The company has shifted from relying on local retailers to procuring and storing products in its own warehouses, improving delivery consistency and quality. 3. **Delivery Mechanism**: Orders placed through the Blinkit app or website are fulfilled by a network of delivery agents, with delivery times often within 10-25 minutes. ### Revenue Model Blinkit generates revenue primarily through: - Commissions charged to sellers listing products on the marketplace - Delivery charges paid by customers ### Key Features and Services - Quick Delivery: Promise of delivering items within 10-25 minutes - Wide Product Range: Over 7,000 products available - User-Friendly Interface: Easy-to-use app and website with personalized recommendations - Scheduled Deliveries: Option to schedule deliveries for later times or dates ### Operations and Expansion As of November 2021, Blinkit: - Operates in more than 30 cities across India - Delivers over 125,000 orders per day - Has received significant funding, with a valuation exceeding $1 billion - Was acquired by Zomato in August 2022 for $568 million in an all-stock deal ### Challenges and Adaptations Blinkit initially faced challenges related to the unreliability of local grocery stores. To address this, the company transitioned to an inventory-based model, improving the consistency and quality of deliveries. In conclusion, Blinkit has transformed the grocery delivery landscape in India by offering a convenient, efficient, and reliable service that caters to the daily needs of its customers.

T

Techstars

Techstars, founded in 2006 in Boulder, Colorado, is a global startup accelerator and venture capital firm that has become a cornerstone of the startup ecosystem. Here's a comprehensive overview of the company: ### Global Presence and Impact Techstars has expanded significantly since its inception, operating accelerator programs across six continents. As of January 2024, it had helped launch approximately 4,100 companies with a combined market capitalization exceeding $116 billion USD. ### Programs and Support The company's flagship offering is a structured accelerator program that admits about 1-2% of applicants. Selected companies receive: - $20,000 in funding - A $100,000 convertible note - Access to the Techstars network - Benefits valued at over $5 million, including $100,000 in AWS credits The program is divided into three phases: mentorship, growth, and investment. ### Investment Strategies Techstars employs multiple investment approaches: 1. Accelerator Funds: Investing in pre-seed stage companies participating in Techstars programs 2. Venture Funds: Investing in follow-on financing rounds of Techstars Accelerator graduates 3. Direct Investing: Allowing investors to invest directly in seed through growth stage financing rounds of Techstars portfolio companies ### Notable Alumni Successful companies that have emerged from Techstars include DigitalOcean, SendGrid, ClassPass, PillPack, and GrabCAD. The success rate is impressive, with 74.5% of Techstars companies raising money within three years of their program, and 18.5% exiting within five years. ### Mission and Values Techstars is committed to: - Cultivating startup culture at the local level - Creating a more sustainable and inclusive world - Supporting entrepreneurs at every stage of their journey - Maintaining honesty, transparency, and an inclusive work environment ### Recent Developments In recent years, Techstars has: - Expanded into Africa - Raised $80 million with J.P. Morgan to invest in underrepresented entrepreneurs - Closed its Boulder and Seattle accelerators - Relocated its headquarters from Boulder to New York City Techstars continues to play a significant role in fostering innovation and supporting early-stage startups globally, with a strong focus on mentorship, funding, and community building.

N

Nscale

Nscale is a hyperscaler company specializing in high-performance, sustainable infrastructure for Artificial Intelligence (AI) and High-Performance Computing (HPC) workloads. Key aspects of Nscale include: ### Founding and Location - Spun out from Arkon Energy, a leading North American data center and hosting business - Headquartered in London with a significant presence in Northern Norway ### Infrastructure and Technology - Vertically integrated model, managing the full AI stack from modular data centers to high-performance compute clusters - Uses AMD Instinct GPUs and AMD EPYC processors in Lenovo ThinkSystem servers optimized for AI workloads ### Sustainability - Commitment to 100% renewable energy - Utilizes natural adiabatic cooling in Northern Norway data centers ### Services and Capabilities - GPU Cloud: Access to thousands of GPUs for AI training, fine-tuning, and inferencing - AI Cloud Platform: Purpose-built for the entire generative AI lifecycle - Turnkey AI Development: Collaborations with partners like Lenovo, Nokia, and AMD ### Partnerships - Strategic partnerships with AMD, Lenovo, and Nokia ### Funding and Expansion - Secured €146 million in Series A funding in December 2024 - Plans to develop new greenfield data centers, with 1.3GW of sites and 120MW planned for 2025 ### Mission and Impact - Aims to democratize high-performance computing for AI - Positioned to accelerate development of groundbreaking technologies and research across various fields

G

Gate.io

Gate.io is a global cryptocurrency exchange founded in 2013 by Lin Han. Headquartered in the Cayman Islands, it serves over 17 million users worldwide, although restricted in several countries including the US, China, and parts of Europe. Key features include: - **Extensive Cryptocurrency Support**: Over 2,500 digital assets and 1,000+ trading pairs. - **Diverse Trading Options**: Spot, margin, futures, and pre-market trading. - **Advanced Features**: Automated trading tools, NFT marketplace, staking, and lending services. - **Native Token**: GateToken (GT) offers benefits like reduced fees and VIP upgrades. - **Security Measures**: Multi-factor authentication, Proof of Reserves, cold storage, and anti-phishing measures. - **Fee Structure**: Tiered based on 30-day trading volume and VIP level. Base spot trading fee is 0.20% for makers and takers. - **Payment Methods**: Bank transfers, credit/debit cards, and crypto deposits. No fiat withdrawals. - **Additional Services**: GateChain (own blockchain ecosystem), Gate Pay (Web3 payment solution), Gate Web3 Wallet, and institutional services. - **Regulatory Compliance**: Licensed by Malta Financial Services Authority and holds a Trust or Company Service Provider license in Hong Kong. Gate.io caters to both novice and advanced traders, offering a comprehensive suite of trading options, tools, and security measures in the cryptocurrency space.